Steward Health Care Chairman and CEO Ralph de la Torre, MD, has "amicably separated" from the system, effective Oct. 1, a Steward spokesperson confirmed to Becker's .

New North Carolina law requires hospitals to have armed law enforcement officers in emergency departments starting Oct. 1, in response to growing violence ...

Toby Cosgrove, former CEO of Cleveland Clinic and Kyle Kiser, CEO of Arrive Health, discuss changes in healthcare, aiming to improve patient affordability. Rising drug costs and lack of cost ...

Biopharmaceutical company Cassava Sciences, along with founder Remi Barbier and former Senior Vice President of Neuroscience Lindsay Burns, PhD, will pay more than $40 million to settle allegations ...

Learn how Mass General Brigham has become the largest hospital-at-home program in the US, treating 50-60 patients daily and aiming for 10% of overall capacity.

Of the respondents who are not currently using generative AI, 64% support their healthcare providers adopting it for care delivery. A majority are comfortable with physicians using the technology to ...

Financial pressures continue to mount for healthcare supply chain leaders as the industry transitions from the traditional fee-for-service payment model to new models driven by value-based care.

Discover the latest CEO moves at California-based hospitals and health systems in September, including resignations and new appointments, reported by Becker's.

CEO Dr. Jawad Shah has grown Insight Health System from a small physician office into a multistate hospital system.

In January 2022, entrepreneur Mark Cuban launched online pharmacy Cost Plus Drugs, which priced 100 medications by their manufacturing fee, a 15% markup, and a shipping and handling fee. Now boasting ...

Chicago-based CommonSpirit posted a $581 million operating loss (-1.5% margin) in fiscal year 2024, up from an operating loss of $1.3 billion (-3.6% margin) posted in 2023, according to its Sept. 26 ...

The phase 3 Tempo-1 trial for tavapadon, a dopamine receptor partial agonist, demonstrated significant efficacy as a monotherapy in early Parkinson's disease. Patients receiving the drug at doses of 5 ...